A professor of surgery and pediatrics at the University of Illinois’ College of Medicine, Mark Holterman, MD, also draws on his extensive medical experience in his work with several external companies. In addition, Dr. Mark Holterman is a founding member of the Alliance for the Advancement of Cellular Therapies (AACT), which he also serves as a board member.
A nonprofit medical organization, the AACT aims to bring together the world’s leading physicians, scientists, researches, and device manufacturers to advance the fields of cell therapy and regenerative medicine. This collaboration is intended to enable the AACT to establish guidelines for clinical translation and best practices in regenerative medicine.
The benefits to AACT membership are numerous. In addition to enjoying discounted rates on a range of conferences and workshops, members receive a regular newsletter featuring the latest news in regenerative medicine and have the opportunity to meet and collaborate with other professionals in the field. Further, AACT members become part of a collective voice capable of expressing opinions directly to the US Food and Drug Administration and European Medicine Agency.